In the News

Blood test for metastatic prostate cancer could suggest better treatment options (Siteman News; Jun 18, 2020)
The Chaudhuri lab’s ctDNA analysis and enrollment protocol titled “Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors” is now on ClinicalTrials.gov under ID# NCT04354064 (ClinicalTrials.gov; April 2020)
Aadel Chaudhuri MD PhD quoted by The Scientist regarding his perspective on conference cancellations in the wake of Coronavirus (The Scientist; March 2020)
Aadel Chaudhuri MD PhD receives a grant from the Institute of Clinical and Translational Sciences to research urine tumor DNA in bladder cancer (Wash U Radiation Oncology News; Jan 2020)
Alvin J. Siteman fund grants $600,000 to Aadel Chaudhuri MD PhD, Chris Maher PhD, and Russell Pachynski MD for advanced-stage prostate cancer research (Siteman News; Dec 2019)
Nadja Pejovic, medical student in Dr. Chaudhuri’s lab, delivers an oral presentation at the Radiation Research Society meeting in the session Imaging and Circulating Biomarkers of Radiation Response (Wash U Rad Onc News; Nov 2020)
Aadel Chaudhuri MD PhD quoted in Cancer Discovery article on the recent TRACERx papers published in Nature Medicine (Cancer Discovery; Nov 2019)
Aadel Chaudhuri MD PhD mentioned as part of the team led by Aaron Newman PhD that developed the CIBERSORTx computational tool for high-resolution in silico tissue dissection (Stanford Medicine News; May 2019)
Aadel Chaudhuri MD PhD awarded a NCI K08 award to study ctDNA as a liver cancer biomarker (Wash U Rad Onc News; Mar 2019)
Aadel Chaudhuri MD PhD mentioned as part of the team behind urine DNA test for bladder cancer detection (Stanford Medicine News; Jan 2019)
Aadel Chaudhuri MD PhD named a 2018 CRF Young Investigator Award winner (Cancer Research Foundation; Dec 2018)
Aadel Chaudhuri MD PhD interviewed on using liquid biopsies to assess radiotherapy response (Imaging Technology News; Nov 2018)
Aadel Chaudhuri MD PhD named 2018 awardee of the Pancreatic Cancer Career Enhancement Program (SPORE; July 2018)
Aadel Chaudhuri MD PhD wins Roentgen Research Award (RSNA; July 2018)
Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer (Cancer Discovery; Dec 2018)
Video interview of Aadel Chaudhuri MD PhD and Maximilian Diehn MD PhD: ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy (cancerNetwork; Nov 14, 2017)
Lung Cancer Recurrence, Predictable at Last? (Inside Science; Nov 8, 2017)
Blood Test for Tumor Cell DNA May Help Predict Localized NSCLC (Oncology Times; Nov 2017)
ASTRO presents award for top resident conference abstract to Aadel Chaudhuri MD PhD (HemOnc Today; Oct 15, 2017)
ASTRO 2017: Predicting Response to Lung Cancer Treatment With Circulating Tumor DNA Analysis (JNCCN360; Oct 2, 2017)
Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (Imaging Technology News; Sep 29, 2017)
Predicting lung cancer recurrence by analyzing circulating tumor DNA (Scope, Stanford Medicine’s blog; Sep 28, 2017)
Liquid Biopsy May Show Poor Prognosis in Early NSCLC (Medpage Today; Sep 27, 2017)
Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (The ASCO Post; Sep 26, 2017)
Biomarker blood test predicts survival following localized lung cancer treatment (Markets Insider; Sep 24, 2017)
Biomarker blood test predicts survival following localized lung cancer treatment (ASTRO; Sep 23, 2017)
ASTRO honors 43 researchers including Aadel Chaudhuri MD PhD who won the Clinical/Basic Science Research Award for top resident abstract at the 2017 Annual Meeting (ASTRO; Aug 30, 2017)
Does Plasma-Based Molecular Testing Have a Role in the Routine Care of Lung Cancer? (Clinical Advances in Hematology & Oncology; Aug 2017)
2017 Conquer Cancer Foundation Grants and Awards Ceremony honors Aadel Chaudhuri MD PhD for winning Young Investigator Award (ASCO; Jun 4, 2017)
Aadel Chaudhuri MD PhD wins RSNA Research Resident/Fellow Grant (RSNA; March 2017)